Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study discovers RX approach that reduces herpes virus infection

04.12.2014

A multi-institutional study reports an effective treatment approach to inhibit and keep latent viruses like herpes simplex from reactivating and causing disease. The work, whose lead author is the late James Hill, PhD, LSU Health New Orleans Professor and Director of Pharmacology and Infectious Disease at the LSU Eye Center, is published in the December 3, 2014, issue of Science Translational Medicine.

The research team, led by Thomas M. Kristie, PhD, Chief of the Molecular Genetics Section in the National Institute of Allergy and Infectious Diseases' Laboratory of Viral Diseases, and also included Timothy Foster, PhD, LSU Health New Orleans Associate Professor of Microbiology, Immunology & Parasitology, studied herpes simplex virus (HSV) infection in several animal models.

They found that an existing drug, tranylcypromine (TCP), blocked a protein called LSD1, which plays a major role in the initiation of herpes simplex virus infection. Current treatments require active viral replication and target late stages of infection, which has led to the development of drug resistance. This study took a different approach - targeting a drug to a protein that controls how genes are turned on and off, early in the viral replication process.

This "epigenetic" approach not only reduced symptoms, but unlike existing treatments, also reduced shedding (the release of virus particles which can transmit the virus even in the absence of symptoms) and forced the virus to remain in a latent stage, preventing its reactivation. Results indicate that even when a virus is not active, drugs modulating epigenetic changes can still treat the infection. Researchers have been pursuing epigenetic-based therapies for cancer, and this study demonstrates its potential as effective antiviral therapy, too.

A high percentage of the human population is infected with the herpes simplex virus and carries the virus in a latent state. After the initial infection, HSV typically goes dormant in cells where it remains. It can then reactivate with a recurrence of symptoms. Even when latent, asymptomatic shedding of the virus continues its transmission.

Neonatal HSV infections can result in death or developmental-neurological issues. HSV eye infections and recurrences are the leading viral cause of infectious blindness or the need for corneal transplants. In addition, along with other herpesviruses, HSV is a complicating factor in immunosuppressed individuals and is a cofactor in HIV transmission.

Although he died before the study was published, LSU Health New Orleans professor Dr. James M. Hill participated in the research. "Dr. Hill was a distinguished and respected herpesvirologist/animal model scientist who passed away approximately a year ago," notes Dr. Foster. "He is lead author on this manuscript due to both his contributions to the work and out of honor and respect for his contributions to the field and all of us involved."

In addition to researchers from the National Institutes of Health and LSU Health New Orleans, scientists from the Food and Drug Administration, Harvard Medical School, Cincinnati Children's

Hospital Medical Center and the University of Alabama Birmingham also participated. The research was supported by grants from the National Institute of Allergy and

Infectious Diseases, National Eye Institute, Research to Prevent Blindness Senior Investigator Award, LSU Health Sciences Center New Orleans, the Louisiana Lions Eye Foundation and U.S. Food and Drug Administration Intramural Funding.

LSU Health Sciences Center New Orleans educates Louisiana's health care professionals. The state's health university leader, LSU Health New Orleans includes a School of Medicine, the state's only School of Dentistry, Louisiana's only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. LSU Health New Orleans faculty take care of patients in public and private hospitals and clinics throughout the region.

In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSU Health New Orleans research enterprise generates jobs and enormous economic impact. LSU Health New Orleans faculty have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease. To learn more, visit http://www.lsuhsc.edu , http://www.twitter.com/LSUHealthNO , or http://www.facebook.com/LSUHSC .

Leslie Capo | EurekAlert!

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>